Key facts
- Roka Furadada’s last known valuation is $5.3M (Apr 2021).
- It has raised $6.9M; the latest was Later Stage VC ($2.7M) in Jan 2026.
- Notable investors include European Innovation Council, European Commission, European Union, Barcelona Activa, Chemostart — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Roka Furadada
- ·The full record, as it builds
Funding rounds
No funding rounds for Roka Furadada are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Roka Furadada
Developer of an ultraviolet radiation filter intended to reduce the incidence of skin cancer. The company's product aims to provide sun protection to customers with an efficient sun cream that is photosensitive, environment-friendly, and has improved non-absorption properties that prevent and treat diseases associated with sun exposure, enabling people to avail of improved sun cream and protect their skin.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Barcelona, Spain
- Founded
- 2019
- Employees
- 21
- Website
- rokafuradada.com/
- Ownership
- Privately Held (backing)
Roka Furadada doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Roka Furadada shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Roka Furadada in its N-PORT filings yet. We sweep new filings monthly.